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Abstract: Background: There is currently no gold standard biomaterial for the 
treatment of periodontal intrabony defects (PIDs).  One of the current options is 
the use of platelet-rich fibrin (PRF). Objective: To determine the clinical effect 
of PRF in the treatment of PID through a systematic review and meta-analysis. 
Materials and Methods: A literature search was conducted up to February 2017 
in the following biomedical databases: Pubmed, Embase, Scielo, Science Direct, 
SIGLE, LILACS and in the Cochrane Central Register of Clinical Trials. The 
selection criteria included: randomized clinical trials published in the last 5 years, 
reporting clinical effects (probing depth, clinical insertion level or gingival reces-
sion), with a follow-up time equal to or greater than 6 months, and sample size 
larger than or equal to 10 patients reporting the use of PRF as a treatment for 
PID. The methodological quality of the studies was analyzed using the Cochrane 
Handbook of Systematic Reviews of Interventions as a reference. Results: The 
search strategy yielded 20 articles. A reduction in probing depth and an increase 
in clinical insertion level or a reduction in gingival recession is reported, when 
using PRF alone or in combination with another biomaterial or substance that 
stimulates tissue regeneration. Conclusion: The literature suggests that the use of 
PRF in the treatment of PIDs has a beneficial clinical effect when compared to 
control treatments.
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INTRODUCTION.
Periodontal disease is characterized by clinical attachment loss with 
subsequent destruction of periodontal tissues.1-3 If left untreated, the 
condition will lead to a premature loss of teeth.2,4 Periodontal treatment 
aims to eliminate the inflammatory process, prevent the progression 
of periodontal disease, maintain natural dentition in optimal health 
and function, and regenerate lost periodontal tissues.3,5,6 Therapeutic 
modalities for restoring the diseased periodontium have shown limited 
potential for good results because they fail to completely regenerate 
periodontal tissues.4,5
One of the consequences of periodontal disease is the appearance 
of periodontal intrabony defects (PIDs). Several biomaterials, such as 
autogenous and allogeneic bone grafts, have been used to treat PIDs. 
However, there is no single graft material to date considered as the gold 
standard for the treatment of DIP.3,5,7 The key to regeneration is to stimulate 
a sequence of curative events that result in the formation of an integrated 
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tissue. Such modulators include the use of growth factors 
(GFs), the application of extracellular matrix proteins 
and binding factors, and the use of bone morphogenetic 
proteins.2,8,9 There is evidence demonstrating the 
effectiveness of GFs in periodontal regeneration.2,4,10,11 
GFs play a key role in the multiplication and development 
of vascular endothelial cells, smooth muscle cells and 
fibroblasts. GFs have multiple effects on cellular remodeling 
phenomena and modulate the inflammatory reaction in the 
healing and tissue regeneration processes.2,3,5,9,12-15 
Platelet-rich fibrin (PRF) as described by Choukroun et 
al.,16 is a second-generation platelet concentrate containing 
platelets and GFs in the form of fibrin membranes prepared 
from the patient's own blood, free of any anticoagulant 
or other artificial biochemical modifications.3,6 PRF 
improves regeneration and wound healing and is superior 
to other platelet concentrates because of its ease of use 
and inexpensive preparation method, as no exogenous 
compounds such as bovine thrombin or calcium chloride 
are needed. PRF has emerged as one of the most promising 
regenerative materials in the field of periodontics.3
Although some studies have evaluated the effect of PRF 
in the treatment of PID, the diverse nature among them 
makes it difficult to obtain clear interpretations. The aim of 
this article was to evaluate the clinical effect of PRF in the 
treatment of periodontal intrabony defects
MATERIALS AND METHODS.
This review was carried out according to a previously 
designed research protocol following the guidelines 
established in the PRISMA standards.17
Search methodology
A broad search strategy was conducted in the biome-
dical databases Pubmed, Embase, Scielo, Science Direct, 
SIGLE (System of Information on Grey Literature in 
Europe), LILACS, IBECS, and in the Cochrane Central 
Register of Clinical Trials. A manual search was also con-
ducted in higher impact journals of periodontology such 
as: Periodontology 2000, Journal of Clinical Periodontolo-
gy and Journal of Periodontology from the 2nd of January, 
2012 until the 28th of February, 2017; using a combina-
tion of topic or thematic headings with the following 
keywords: ("fibrina rica en plaquetas” OR "platelet-rich 
fibrin” OR "PRF" OR "plasma rich in growth factors") 
AND ("defecto intraóseo" OR "defecto periodontal” OR 
"infrabony defect" OR "periodontal defect").
 Selection criteria
The following inclusion criteria were considered: arti-
cles reporting the use of PRF in the treatment of PID; 
reporting clinical effects (reduction in probing depth, in-
crease in clinical insertion level and reduction in gingival 
recession) when using   in the treatment of PID; articles 
published in the last 5 years, reporting a follow-up time 
equal to or greater than 6 months, with sample sizes equal 
to or greater than 10 patients.Articles reporting the use 
of PRF in the control group, and articles published in 
non-indexed journals were excluded from the study.
Process of selection and extraction of data
Titles and abstracts of all the articles complying with 
the aforementioned inclusion and exclusion criteria were 
reviewed. Full texts of the articles that seemed to meet 
the selection criteria were obtained in order to assess the 
bias risk. A checklist was made in duplicate to evaluate 
the studies and to extract the information of interest. 
Two reviewers (LG and EI) independently performed the 
evaluation of the articles regarding title, author, year of 
publication, type of study, number of patients, ages of 
patients, follow-up time, country where it was conducted, 
number of areas treated per group, number of patients per 
group, type of PID treated, reduction in probing depth, 
increase in clinical insertion level, reduction in gingival 
recession, number of centrifugations, primers used, post-
surgical medication and risk of bias. For the resolution 
of any discrepancy between the reviewers, they met and 
discussed with a third reviewer (SR) in order to reach an 
agreement.
Assessment of the methodological quality and risk of 
bias of the studies
For the assessment of the methodological quality 
and risk of bias, each study was analyzed according 
to the Cochrane Handbook of Systematic Reviews 
of Interventions.18  Each study was evaluated in seven 
domains: selection bias (random sequence generation and 
concealment of allocation), performance bias (blinding of 
participants and research staff), detection bias (blinding 
of outcome assessors), attrition bias (incomplete outcome 
data), reporting bias (selective reporting of results), and 
other biases. Each domain was assessed as high, low, or 
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unclear risk.
Analysis of results
Data from each study were placed and analyzed with 
RevMan 5.3 (Cochrane Group, UK). For performing 
the meta-analysis, results of the studies were combined 
independent of the follow-up period length.
RESULTS.
The initial search in the biomedical databases 
yielded107 titles; Figure 1 shows the article selection 
flowchart. Table 1 also shows the characteristics and 
variables considered in the 20 selected articles. Figure 2 
presents the analysis of the methodological quality and 
the risk of bias of the studies.
Figure 3 shows the forest plot for the reduction in probing 
Figure 1. Article selection flowchart.
Articles identified in electronic 
searches (database) and journals.
n=107
Articles excluded for being repeated.
n=12
Articles excluded after evaluating their titles.
n=49
Articles excluded after evaluating their abstracts.
n=26




Articles included in meta-analysis.
n=19
Articles identified to read their titles
n=95
Articles identified to read their abstracts.
n=46
Articles identified in the systematic
review n=20












Random sequence generation (selection blas).
Allocation concealment (selection blas).
Blinding of participants and personnel 
(performance blas).
Blinding of outcome assessment (detection blas).
Incomplete outcome data (atrtrition blas).
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  PRF               Control       Mean difference
Study or Subgroup Mean SD  Total Mean SD Total Weight  IV Random, 95% CI Year
Only PRP 
Pradeep 2012 3.77 1.19 16 2.97 0.93 17 3.8% 0.80 (0.07, 1.53) 2012
Agarwal 2016 4.67 0.9 15 2.4 0.63 15 4.3% 2.27 (1.71, 2.83) 2012
Pradeep 2012a 3.9 1.09 30 2.97 0.93 30 4.4% 0.93 (0.42, 1.44) 2012
Gupta 2014 1.8 0.77 22 1.8 0.56 22 4.6% 0.00 (-0.40, 0.40) 2014
Mathur 2015 2.67 1.29 19 2.4 1.06 19 3.8% 0.27 (-0.48, 1.02) 2015
Ajwani 2015 1.9 0.74 20 1.6 0.84 20 4.4% 0.30 (-0.19, 0.79) 2015
Shah 2015 3.67 0.69 20 3.7 0.68 20 4.5% -0.03 (-0.45, 0.39) 2015
Pradeep 2015 4 0.18 30 3 0.28 30 5.0% 1.00 (0.88, 1.12) 2015
Panda 2016 3.88 1.15 16 3.19 1.33 16 3.5% 0.69 (-0.17, 1.55) 2016
Kanoriya 2016 3.7 0.91 30 2.86 0.68 30 4.6% 0.84 (0.43, 1.25) 2016
Chatterjee 2016 5.46 1.04 32 3.68 0.72 32 4.5% 1.78 (1.34, 2.22) 2016
Martande 2016 3.76 1.12 30 2.76 1.43 30 4.0% 1.00 (0.35, 1.65) 2016
Chadwick 2016 2.12 1.41 17 2 1.37 19 3.4% 0.12 (-0.79, 1.03) 2016
Chandradas 2016 3.82 0.75 12 3 1.21 12 3.6% 0.82 (0.01, 1.63) 2016
Subtotal (95% CI)   309   312 58.4% 0.79(0.46, 1.11)
Heterogeneity: Tau2=0.29; Chi2=91.41, d
f 
=13 (p=0.00001); I2=86%
Test for overall effect: Z=4.77 (p<0.00001)
PRP combined with another biomaterial
Pradeep 2012a 4.97 0.98 30 2.97 0.93 30 4.4% 1.30 (0.82, 1.78) 2012
Bansal 2013 4 0.82 10 3.1 0.74 10 3.9% 0.90 (0.22, 1.58) 2013
Pradeep 2015 4.9 0.3 30 3 0.28 30 5.0% 1.90 (1.75, 2.05) 2015
Agarwal 2016 4.15 0.84 30 3.6 0.51 30 4.7% 0.55 (0.20, 0.90) 2016
Kanoriya 2016 4.53 0.81 30 2.86 0.68 30 4.6% 1.67 (1.29, 2.05) 2016
Gamal 2016 3.6 0.45 10 3.8 0.42 10 4.6% -0.20 (-0.58, 0.18) 2016
Chandradas 2016 4.25 1.48 12 3 1.21 12 3.0% 1.25 (0.17, 2.33) 2016
Martande 2016 4.06 1.22 30 2.76 1.43 30 4.0% 1.30 (0.63, 1.97) 2016
Turkal 2016 4 1.38 28 3.88 1.26 28 3.9% 0.12 (-0.57, 0.81) 2016
Sezgin 2017 4.93 1.22 15 4.21 1.21 15 3.5% 0.72 (-0.15, 1.59) 2017
Subtotal (95% CI)   225   225 41.6% 0.96 (0.40, 1.52)
Heterogeneity: Tau2=0.72;  Chi2=154.21,  d
f 
=9 (p=0.00001); I2=94%
Test for overall effect: Z=3.34 (p=0.0008)
Total (95% CI)   534   537 100.0% 0.86 (0.56, 1.15)
Heterogeneity: Tau2=0.45; Chi2=295.33,  d
f 
=23 (p<0.00001); I2=92%
Test for overall effect: Z=5.71 (p=0.007)
Test for subgroup differences: Chi2=0.27, d
f 
=1 (p<0.61); I2=0%
Figure 3. Forest plot of the event "Reduction of probing depth when using
 PRF in the treatment of periodontal intrabony defects".
Mean difference 
IV Random, 95% CI
Favours 
(Control)
-2 0 2-4 -4
Favours 
(PRP)
depth when using PRF in the treatment of periodontal 
intrabony defects. Figure 4 shows the forest plot for the 
increase in clinical insertion level when using PRF in the 
treatment of periodontal intrabony defects. Figure 5 presents 
the forest plot for the reduction in gingival recession when 
using PRF in the treatment of periodontal intrabony defects.
DISCUSSION.
Results revealed that the use of PRF in the treatment 
of PID produced an increase in the clinical insertion level, 
a reduction in probing depth, and a reduction in gingival 
recession significantly greater than the control treatment. 
Subgroup analysis showed that all these clinical effects 
were similarly beneficial if PRF was used alone, or if 
PRF was used in combination with another biomaterial 
or substance that stimulates tissue regeneration. In this 
study, a random effects model for the meta-analysis was 
used. In addition, it was found that there was no difference 
if the RCT had a parallel21–23,26–28,32,34,37,38 or cross-over 
design.19,24,25,29–31,33,35,36 
The studies showed positive clinical effects for the use of 
PRF in the treatment of PID. This is similar to the findings 
reported by Smail et al.,39 who performed a study that did 
not provide sufficient evidence for the systematic differences 
in estimates of the effect of interventions between split-
mouth and parallel-arm RCTs for continuous or binary 
Arbildo H, Gamarra L, Rojas S,  Infantes E, Lamas C & Vásquez H. 
Clinical effect of platelet rich fibrin in the treatment of periodontal intrabony defects. Systematic review and meta-analysis.
 J Oral Res 2017; 6(5):127-135. doi:10.17126/joralres.2017.036
133ISSN Online 0719-2479 - www.joralres.com © 2017
  PRF               Control       Mean difference
Study or Subgroup Mean SD  Total Mean SD Total Weight  IV Random, 95% CI Year
Only PRP 
Pradeep 2012 3.17 1.29 16 2.83 0.91 17 3.8% 0.34(-0.43, 1.11) 2012
Rosamma 2012 4.73 0.88 15 1.4 1.06 15 4.0% 3.33 (2.63, 4.03) 2012
Pradeep 2012a 3.03 1.16 30 2.67 1.09 30 4.2% 0.36 (-0.21, 0.93) 2012
Gupta 2014 1.87 0.92 22 2 0.53 22 4.5% -0.13 (-0.57, 0.31) 2014
Ajwani 2015 1.8 0.63 20 1.3 0.68 20 4.5% 0.50 (0.09, 0.91) 2015
Pradeep 2015 4.03 0.18 30 2.96 0.18 30 4.9% 1.07 (0.98, 1.16) 2015
Mathur2015 2.53 1.06 19 2.67 1.63 19 3.6% -0.14(-1.01, 0.73) 2015
Shah 2015 2.97 1.56 20 2.97 1.68 20 3.3% 0.00 (-1.00, 1.00) 2015
Chandradas 2016 3.27 0.65 12 2.25 0.62 12 4.4% 1.02 (0.51, 1.53) 2016
Chadwick 2016 1.03 0.86 17 1.16 1.33 19 3.9% -0.13 (-0.85, 0.59) 2016
Chatterjee 2016 6.57 1.45 32 4.14 0.76 32 4.2% 2.43 (1.86, 3.00) 2016
Kanoriya 2016 4.2 0.66 30 3.03 0.18 30 4.8% 1.17 (0.93, 1.41) 2016
Martande 2016 3.4 1.13 30 2.5 1.33 30 4.1% 0.90 (0.28, 1.52) 2016
Panda 2016 4.44 1.5 1.6 3.38 1.45 16 3.2% 1.06 (0.04, 2.08) 2016
Subtotal (95% CI)   3.09   312 57.3% 0.87(0.51, 123)
Heterogeneity: Tau2=0.37; Chi2=129.34, d
f 
=13 (p=0.00001); I2=90%
Test for overall effect: Z=4.72 (p<0.00001)
PRP combined with another biomaterial
Pradeep 2012a 3.67 1.03 30 2.67 1.09 30 4.3% 1.00 (0.46, 1.54) 2012
Bansal 2013 3.4 0.61 10 2.3 0.69 10 4.2% 1.10 (0.53, 1.67) 2013
Pradeep 2015 4.9 0.3 30 2.96 0.18 30 4.9% 1.94 (1.81, 2.07) 2015
Agarwal 2016 3.73 0.74 30 2.61 0.68 30 4.6% 1.12 (0.76, 1.48) 2016
Chandradas 2016 3.92 0.9 12 2.25 0.62 12 4.1% 1.67 (1.05, 2.29) 2016
Gamal 2016 1.2 0.36 10 1.8 0.5 10 4.6% -0.60 (1.05, 2.29) 2016
Turkal 2016 3.42 1.28 28 3.29 1.3 28 4.0% 0.13 (-0.55, 0.81) 2016
Martande 2016 3.66 1.42 30 2.5 1.33 30 4.0% 1.16 (0.46, 1.86) 2016
Kanoriya 2016 5.16 0.46 30 3.03 1.18 30 4.8% 2.13 (1.95, 2.31) 2016
Sezgin 2017 4.47 1.6 15 3.27 1.34 15 3.2% 1.20 (0.14, 2.26) 2017
Subtotal (95% CI)   225   225 42.7% 1.10 (0.56, 1.63)
Heterogeneity: Tau2=0.67;  Chi2=220.89,  d
f 
=9 (p=0.00001); I2=96%
Test for overall effect: Z=4.01 (p<0.0001)
Total (95% CI)   534   537 100.0% 0.96 (0.65, 1.28)
Heterogeneity: Tau2=0.52; Chi2=475.30,  d
f 
=23 (p<0.00001); I2=95%
Test for overall effect: Z=6.02 (p<0.00001)
Test for subgroup differences: Chi2=0.49, d
f 
=1 (p=0.48); I2=0%
Figure 4. Forest plot of the event "Increase in clinical insertion level when using 
PRF in the treatment of periodontal intrabony defects".
Mean difference 
IV Random, 95% CI
Favours 
(Control)
-2 0 2-4 -4
Favours 
(PRP)
data. This review also demonstrates that PRF does not have 
a clear standard protocol because the type of centrifuge 
and configuration also differ from one study to another. 
Therefore more standardized protocols are needed to allow 
for a better comparison and homogenize the results.
One strength of this systematic review was the selection 
of the studies, because an exhaustive search was performed 
in the most important databases and strict inclusion 
criteria were followed. However, there are also limitations 
such as the presence of many RCTs that presented a high 
and unclear risk of bias. Another positive aspect is the 
comparison of these results with other systematic reviews 
on this subject.40,41 These reviews confirm that using PRF 
produces a positive and beneficial clinical effect in the 
treatment of PIDs. It is important to consider that these 
reviews included RCTs published in years prior to those 
included in this study.
However, the promising effect of PRF for the treatment 
of PIDs cannot yet fully accepted. Most of the RCTs 
show a high heterogeneity and were conducted primarily 
in European and Asian countries, with only two from 
North America and one from Africa. As each continent 
and country has its own culture and diet, these factors 
can influence the clinical effects of PRF. It is advisable to 
carry out well-designed RCTs dealing with this issue in 
countries in other continents, especially in Latin America, 
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because Latin American countries have the greatest genetic 
diversification, culture, food and a wide range of climates.
CONCLUSION.
The clinical effect of PRF in the treatment of PID is 
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Chandradas 2016  -0.17 0.39 12 -1.33 0.78 12 1.2% 1.16 (0.67, 1.65) 2016
Kanoriya 2016 0.35 0.11 30 -0.06 0.07 30 12.4% 0.41 (0.36, 0.45) 2016
Martande 2016 0.29 0.18 30 -0.06 0.02 30 11.5% 0.35 (0.29, 0.41) 2016
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Subtotal (95% CI)   215   215 48.1% 0.41 (0.33, 0.50)
Heterogeneity: Tau2=0.01;  Chi2=35.10,  d
f 
=8 (p=0.00001); I2=77%
Test for overall effect: Z=9.64 (p<0.0001)
Total (95% CI)   470   473 100.0% 0.38 (0.32, 0.44)
Heterogeneity: Tau2=0.01; Chi2=111.17,  d
f 
=20 (p<0.00001); I2=82%
Test for overall effect: Z=13.27 (p<0.00001)
Test for subgroup differences: Chi2=1.49, d
f 
=1 (p=0.22); I2=32.9%
Figure 5. Forest plot of the event "Reduction in gingival recession when using 
PRF in the treatment of periodontal intrabony defects".
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